Archives

February 3, 2020

NTP Board of Scientific Counselors Will Discuss Human Exposure to Nanoplastics and Microplastics

The National Toxicology Program (NTP) published a Federal Register notice on January 31, 2020, announcing that the Board of Scientific Counselors (BSC) will meet on February 21, 2020.  During the meeting, BSC will review and provide advice on programmatic activities.  According to the preliminary agenda for the meeting, the meeting will include a presentation by Dr. Anil Patri, Food and Drug Administration, National Center for Toxicological Research,...
April 18, 2017

NIOSH BSC Meeting Includes Presentation on Nanotoxicology

On April 12, 2017, the National Institute for Occupational Safety and Health (NIOSH) Board of Scientific Counselors (BSC) held its 68th meeting.  The BSC’s primary activity is to provide advice on NIOSH’s occupational safety and health research and prevention programs.  The BSC also advises on standards of scientific excellence, current needs in the field of occupational safety and health, and the applicability and dissemination of research findings.  Dr. Jenny Roberts,...
October 25, 2007

NTP Board Will Review Proposed Research and Testing of Nanoscale Gold

On October 17, 2007, the National Toxicology Program (NTP) announced that the Board of Scientific Counselors (BSC) will meet on December 6, 2007. The notice states that the preliminary agenda topics include review of NTP study nominations and proposed research and testing activities for several substances, including nanoscale gold. Written comments are due November 21, 2007. The deadline for pre-registration is November 29, 2007. NTP will post when...
June 27, 2007

NTP Board of Scientific Counselors Reviews Nomination of Nanoscale Silver for Testing

At its June 22, 2007, meeting, the National Toxicology Program’s (NTP) Board of Scientific Counselors (BSC) reviewed nominations of several substances for testing, including nanoscale silver. The Food and Drug Administration nominated nanoscale silver for toxicological studies “based on (a) increasing widespread use in drug, food and cosmetic products, and (b) the general lack of data on the toxicology and pharmacokinetics of these materials.” Comments on the...